Delaware Senate Bill SB160

Delaware 2025-2026 Regular Session

• Introduced: 5/21/25
• Refer: 5/21/25
• Engrossed: 6/11/25
• Refer: 6/12/25
• Enrolled: 6/26/25
• Passed: 7/21/25

Caption

An Act To Amend Title 14 Of The Delaware Code Relating To Providing Information On Type 1 Diabetes.

Summary

SB160 requires the Delaware Department of Health and Social Services, in consultation with the Department of Education, to post existing informational materials about type 1 diabetes on the department’s website. It also requires each local education agency to make those materials available to parents or guardians of enrolled students. The bill is focused on awareness and early identification rather than creating a new clinical program or mandate for schools to diagnose or treat diabetes. The required materials must explain what type 1 diabetes is, describe risk factors and warning signs, and advise parents or guardians to consult a primary care provider if a student shows warning signs. The materials must also describe the screening process, explain what test results may mean, and recommend follow-up with a primary care provider and, when appropriate, a specialist such as an endocrinologist after diagnosis. The bill includes a delayed effective date tied to August 1 of the year following enactment, or the next August 1 if enacted after August 1, 2025.

Impact

SB160 amends Title 14 of the Delaware Code by adding a new section requiring state education and health agencies to distribute existing type 1 diabetes informational materials. It does not create a new benefit program, reporting requirement, or medical screening mandate, but it does impose a notice-and-distribution obligation on the Department of Health and Social Services and local education agencies. The practical effect is to standardize access to diabetes education materials for families across Delaware schools and to encourage earlier consultation with medical providers when warning signs appear.

Sentiment

The available voting history shows strong bipartisan support and no recorded opposition: the Senate passed the bill 19-0 and the House passed it 40-0. That unanimous support suggests the bill was viewed as a low-conflict public health and student-information measure. No committee transcripts were provided, but the vote totals indicate broad agreement on the value of increasing awareness of type 1 diabetes among parents and guardians.

Contention

There is little evidence of substantive controversy in the available record. The main policy choice is whether schools and state agencies should be required to distribute existing diabetes information, and the bill limits that obligation to posting and sharing materials already available rather than creating new content or medical duties. Any potential concern would likely center on administrative implementation for local education agencies or on the scope of school involvement in health education, but the unanimous votes suggest those concerns were not significant.